danthron has been researched along with Atherosclerosis in 1 studies
danthron: structure
chrysazin : A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8.
Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, X | 1 |
| Zhang, Y | 1 |
| Lin, B | 1 |
| Zhou, Y | 1 |
| Suo, W | 1 |
| Wei, J | 1 |
| Zhang, L | 1 |
| Lin, J | 1 |
| Xiao, F | 1 |
| Zhao, L | 1 |
| Lin, Y | 1 |
1 other study available for danthron and Atherosclerosis
| Article | Year |
|---|---|
Danthron attenuates experimental atherosclerosis by targeting foam cell formation.
Topics: Animals; Anthraquinones; Atherosclerosis; Foam Cells; Macrophages; Male; Mice | 2021 |